Myasthenia Gravis Foundation of America
Non-Profit & Charitable Organizations · Massachusetts, United States · <25 Employees
View Company Info for Free
About
Headquarters
290 Turnpike Rd Ste 5-315, Westborough, Massach...Phone Number
(800) 541-5454Website
www.myasthenia.orgRevenue
<$5 MillionIndustry
Who is Myasthenia Gravis Foundation of America
The Myasthenia Gravis Foundation of America is dedicated to the fight against myasthenia gravis. By raising research funds to find a cure and raising awareness of the neuromuscular disease. The Myasthenia Gravis Foundation of America is headquartered in NEW York City, New York.Explore more
Myasthenia Gravis Foundation of America Org Chart
Is Myasthenia Gravis Foundation of America your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Myasthenia Gravis Foundation of America, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Myasthenia Gravis Foundation of America is spiking on competitors!
Click to see if Myasthenia Gravis Foundation of America had a recent Job posting/layoffs
Earning: See what the market has to say on Myasthenia Gravis Foundation of America recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Myasthenia Gravis Foundation of America
Funding: Get notified immidiatlly once Myasthenia Gravis Foundation of America has new funding data
Check if Myasthenia Gravis Foundation of America has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Myasthenia Gravis Foundation of America launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Myasthenia Gravis Foundation of America
Find 3 more new buyers
Compare Similar Companies to Myasthenia Gravis Foundation of America
Compare insights from companies similar to Myasthenia Gravis Foundation of America, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Myasthenia Gravis Foundat...
<$5M
-
Myasthenia Gravis Foundation of America Employee Growth Rate
View Myasthenia Gravis Foundation of America’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Myasthenia Gravis Foundation of America Tech Stack
A closer look at the technologies used by Myasthenia Gravis Foundation of America
Myasthenia Gravis Foundation of America News & Media
Seismic Therapeutic Presents New Preclinical Data on S-1117 in Autoantibody-Mediated Diseases Including Myasthenia Gravis at MGFA Scientific Session at AANEM Annual Meeting
WATERTOWN, Mass.--(BUSINESS WIRE)--Seismic Therapeutic, Inc., the machine learning immunology company, today announced the presentation of new preclinical data for its pan‑immunoglobulin G (IgG) sculpting enzyme candidate, S-1117, at the Myasthenia Gravis Foundation of America (MGFA) Scientific Session at the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) 2024 annual meeting in Savannah, Georgia. S-1117 is a novel engineered Fc-fused pan-IgG protease targeting IgG
Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting
Company continues to expect to hold an End-of-Phase 2 meeting with the FDA by year-end Company continues to expect to hold an End-of-Phase 2 meeting with the FDA by year-endargenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions
Long-term and real-world data of VYVGART® (efgartigimod alfa-fcab) and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrate speed of onset, depth of response, and durability of responseUCB showcases new data for gMG management at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA) Scientific Session
UCB will contribute 14 presentations, including an oral presentation, selected to feature across the AANEM and MGFA meeting, emphasizing UCB's leadership in neuromuscular research Presentations showcase new data for UCB's gMG treatments, including post hoc analyses highlighting the...Myasthenia Gravis Foundation of America (MGFA) Launches New MGFA Helpline to Address MG-related Questions and Provide Emotional Assistance
Toll-free phone number (833) 647-8764 In U.S. and Canada Trained counselors to provide general resource guidance for the MG Community BOSTON, June 18, 2024 /PRNewswire/ -- Myasthenia Gravis Foundation of America (MGFA™), the largest, leading patient advocacy organization solely dedicated...
Read more news
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Myasthenia Gravis Foundation of America
Sign Up for FreeTo access detailed company insights
The Myasthenia Gravis Foundation of America is dedicated to the fight against myasthenia gravis. By raising research funds to find a cure and raising awareness of the neuromuscular disease. The Myasthenia Gravis Foundation of America is headquartered in NEW York City, New York.... Read More
